Zdrowie i gospodarka · 28/08/2015

FDA Releases Draft Guidance on Nonproprietary Naming of Biological Products

The US Food and Drug Administration (FDA) has released a draft guidance on the nonproprietary naming of biological products, which will require these products to have a unique four-letter suffix to improve pharmacovigilance and differentiate them from interchangeable products.